Metabolic liver disease might not get as much attention as heart disease or diabetes, but it affects around one in four ...

Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing next-generation peptide-based therapeutics for liver and cardiometabolic diseases, today announced that the ...

Prior to starting the trial, the participants also had moderate to high levels of scar tissue in the liver, known as stage 2 ...

Semaglutide effectively treats liver disease in two thirds of patients, new research has found. Results from the ESSENCE ...

Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.

Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic dysfunction-associated steatohepatitis (MASH) ...

The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH.

The following is a summary of "Metabolic score for visceral fat is correlated with all-cause and cardiovascular mortality ...

You do not have to consume these drinks in order to enjoy their taste. Try swapping them with lemon drinks made at home, ...

NAFLD is a condition where too much fat builds up in the liver cells, even though a person drinks little or no alcohol. It is ...

Researchers in South Korea have developed an organoid disease model and non-destructive stiffness analysis technology for ...

In a new study, researchers showed that resistant starch can help lower harmful fat levels in the liver. Resistant starch is ...